"Manage Diabetes with GLISAXAPIN M 2.5/500 (Saxagliptin, Metformin)"

GLISAXAPIN M 2.5/500 

Saxagliptin (2.5mg), Metformin HCI (ER) (500mg)

Introduction

Saxagliptin (2.5mg) and Metformin HCI (ER) (500mg), marketed as GLISAXAPIN M 2.5/500, is a powerful combination medication used to manage type 2 diabetes. By combining the DPP-4 inhibitory action of Saxagliptin with the glucose-lowering effects of extended-release Metformin, this medication provides a comprehensive approach to controlling blood sugar levels.

Mechanism of Action

Saxagliptin works by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4). This enzyme is responsible for breaking down incretin hormones, which regulate blood glucose levels. By inhibiting DPP-4, Saxagliptin increases the levels of active incretin hormones, enhancing insulin secretion and reducing glucagon levels. This helps to control blood sugar levels, particularly after meals.

Metformin primarily works by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues. The extended-release (ER) formulation ensures a gradual release of the medication, providing consistent blood sugar control throughout the day and reducing gastrointestinal side effects often associated with immediate-release Metformin.

Benefits of Combination Therapy

GLISAXAPIN M 2.5/500 offers several significant benefits for patients with type 2 diabetes:

1. Enhanced Glycemic Control: The dual mechanism targets different pathways to effectively lower blood glucose levels and improve HbA1c levels.
2. Reduced Risk of Hypoglycemia: Combining Saxagliptin and Metformin minimizes the risk of low blood sugar episodes, especially compared to some other diabetes medications.
3. Weight Neutral: This combination therapy does not contribute to weight gain, making it suitable for patients concerned about weight management.

Usage and Dosage

The typical dosage of GLISAXAPIN M 2.5/500 is one tablet taken once daily with food to reduce gastrointestinal side effects. It is important to follow the healthcare provider's instructions and not to adjust the dose without consultation. Consistent daily intake is crucial for maintaining stable blood sugar levels.

Potential Side Effects

Common side effects may include:

• Upper respiratory tract infection
• Headache
• Gastrointestinal issues (e.g., diarrhea, nausea)
• Urinary tract infection

Most side effects are mild and transient. However, if any severe or persistent side effects occur, it is essential to consult a healthcare provider immediately.

Conclusion

Saxagliptin (2.5mg) and Metformin HCI (ER) (500mg) (GLISAXAPIN M 2.5/500) is an effective and well-tolerated option for managing type 2 diabetes. This combination therapy provides significant blood sugar control with minimal risk of hypoglycemia and weight gain. Consult your healthcare provider to determine if this medication is right for your diabetes management.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

   BUY NOW